Timea M. Helter
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trial.
Journal: BJPsych open
Published: April 13, 2026
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trial.
Journal: The Lancet regional health. Europe
Published: August 11, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.
Journal: Health technology assessment (Winchester, England)
Published: June 02, 2025
Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trial.
Journal: Journal of affective disorders
Published: April 17, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study).
Journal: Journal of psychopharmacology (Oxford, England)
Published: January 20, 2025
Comparison of capability and health-related quality of life instruments in capturing aspects of mental well-being in people with schizophrenia and depression.
Journal: BJPsych open
Published: June 27, 2022
Exploring the over-time, multifaceted impacts of three COVID-19 lockdowns on aspects of capability, wellbeing and mental health across vulnerabilities in Austria.
Journal: Scientific reports
Published: March 15, 2022
Does the relative importance of the OxCAP-MH's capability items differ according to mental ill-health experience?
Journal: Health and quality of life outcomes
Published: March 02, 2022
Patient-reported outcome measures suitable for quality of life/well-being assessment in multisectoral, multinational and multiperson mental health economic evaluations.
Journal: Evidence-based mental health
Published: August 29, 2021
Internal and external aspects of freedom of choice in mental health: cultural and linguistic adaptation of the Hungarian version of the Oxford CAPabilities questionnaire-Mental Health (OxCAP-MH).
Journal: BMC psychology
Published: November 10, 2020
Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study).
Journal: BMC psychiatry
Published: November 09, 2020
Last Updated: 09/26/2026